Navigation Links
Stoneville Cotton Seed from Bayer CropScience Celebrates 90 Years of Performance
Date:3/1/2013

Research Triangle Park, NC (PRWEB) March 01, 2013

Stoneville® Cotton Seed was founded to increase the economic value of an acre of cotton, and that purpose still guides the cottonseed brand today. Generations of growers have trusted the brand’s early seedling vigor, consistent stand establishment and higher yield potential. Today, Stoneville is breaking new ground with industry-first technology while yields and profitability continue to improve.

“Our goal is to make the cotton grower profitable and Stoneville gives growers that opportunity,” said Jeff Brehmer, U.S. product manager for FiberMax® and Stoneville, Bayer CropScience. “Since Bayer CropScience bought Stoneville in 2007, we have focused on improving the germplasm and introgressing the best traits. You see that today with the 2013 advancement of two new Stoneville varieties, ST 4946GLB2 and ST 6448GLB2, which are the first Stoneville varieties to offer multiple herbicide tolerance with GlyTol® and LibertyLink® traits. This is the most complete cotton technology on the market today.”

Stoneville leading the cotton industry is not new. In 1995, Stoneville became the world’s first company to commercialize genetically engineered cottonseed with BXN. Bud Hughes was with Stoneville for 15 years and served as president and CEO for 11 years. Hughes, now a partner in the crop genetics M&A firm Verdant Partners LLC, led the company through the transition to transgenic cotton. Hughes also oversaw strategic germplasm acquisitions that broadened and accelerated germplasm development.

“We were proud of BXN. After decades
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Stoneville Offers Two New Varieties With GlyTol and LibertyLink Traits
2. Cotton fabric cleans itself when exposed to ordinary sunlight
3. 2012 Cotton Biotechnology Award Recipients
4. Bayer HealthCares Cotavance® Drug Eluting Balloon With Paccocath® Technology Reduced Five-Year Target Lesion Revascularization Rates by 59 Percent in PAD Patients Compared to Those Treated With Uncoated Balloon
5. Bayer Advanced(TM) Sets Sights on New Partnerships in 2013
6. QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies
7. Bayer CropScience Announces LibertyLink LinkUp Offer Increased for 2013 Season
8. Bayer Bee Care Center Helps Solve Bee Health’s Toughest Challenges
9. Growers Choose the Bayer CropScience LibertyLinkSystem for Yield and Performance
10. Bayer CropScience Provides a Glimpse of SeedGrowth™ Innovation
11. Bayer CropScience Launches Third Annual Young Farmer Sustainability Award Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... A recent study from researchers in ... find that those who took probiotics were able to run ... study showed that in extreme heat conditions, probiotics were able ... acne treatment explains what this new discovery means ... their skin condition. , While researchers tote the benefits ...
(Date:5/21/2013)... -- First patients dosed with PSX1002, an ... using Prosonix, particle engineering platform Prosonix, an ... Respiratory Medicines by Design , has initiated a ... its effect on lung function and the safety of ... severe chronic obstructive pulmonary disease (COPD). The first two ...
(Date:5/21/2013)... May 21, 2013 Custom Learning ... reporting eLearning solution using Tin Can API combined ... tool. CLD is a leading developer of training ... device companies worldwide. , Tin Can API ... helps learners and trainers more accurately measure the ...
(Date:5/21/2013)... Alpha Source, Inc., a Wisconsin-based ... exhibiting for the 13th consecutive year at the ... 2013 Conference and Expo. The conference brings together ... healthcare technologies. This year’s event will be held ... , The three-day event draws over 1,500 healthcare ...
Breaking Biology Technology:Adult Acne Treatment, Probiotic Action Shares Insight on New Findings Between Probiotics and Heat Tolerance, and What It Means for Acne Sufferers 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 2CLD Integrates Tin CAN API with its eLearning Solutions and Launches its Excelerometer Tracking Statement Dashboard 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... It's been a long campaign season, and you've been poked ... national press corps member. John Kerry drank a beer at ... at your local kindergarten. Dick Cheney was spotted more in ... in the last four years. John Edwards has been in ...
... drug purification products Business filings serves ... dip in third-quarter earnings from mild weather ... Wisconsin-based Analogix joins French company to ... maker of drug-purification devices based in Burlington, Wisconsin, has ...
... more hours in the day so I can get more done (like ... We "fall back" into standard time and get another hour. But what ... my desk, which I always promise to do when I have more ... wanted to share in this column. Here they are, in no particular ...
Cached Biology Technology:Twenty ways you can tell this campaign has finally pushed you over the edge 2Tech Digest: whats moving in the Midwest (11/1/04) 2Music, mail, databases and printing from a technologists desk 2Music, mail, databases and printing from a technologists desk 3
(Date:5/21/2013)... The largest gathering of biomass experts , ... , When? 03-07 June 2013 ... scientific research, resource assessment, market and policy developments, manufacturing ... the world and benefiting from its 2013 edition from ... more than 60 countries, more than 240 plenary and ...
(Date:5/21/2013)... May 21, 2013 Royal Philips Electronics (NYSE: ... world,s first portable ultrasound with Philips, industry leading Live ... The CX50 xMATRIX with available Live 3D TEE and ... at the EuroPCR, official meeting for the European ... Since its launch in 2012, Philips CX50 xMATRIX ...
(Date:5/20/2013)... antibiotic colistin are also commonly resistant to antimicrobial ... a study in mBio , the online ... Cross-resistance to colistin and host antimicrobials LL-37 and ... attack, could mean that patients with life-threatening multi-drug ... immune response. Colistin is a last-line drug for ...
Breaking Biology News(10 mins):21st European Biomass Conference and Exhibition 221st European Biomass Conference and Exhibition 321st European Biomass Conference and Exhibition 4Philips CX50 xMATRIX now offers world-class interventional and diagnostic features on single portable system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 2Resistance to last-line antibiotic makes bacteria resistant to immune system 3
... Alabama used worms to reel in information that they hope ... may be exploited to treat epilepsy. In a new research ... the researchers explain how the transparent roundworm, C. elegans ... transport of a molecule (gamma-aminobutyric acid or "GABA") that if ...
... b3c newswire / - Critical Outcome Technologies ... from animal experiments carried out at a prominent Canadian ... to the already impressive data package for COTI-2, demonstrating ... first line therapies with low toxicity in seven different ...
... the primary cause of cancer mortality in children. Even ... tremendously from the stressful treatment which can be harmful ... need for target-oriented, gentle treatment methods. The most important ... approximately one hundred young patients each year in Germany, ...
Cached Biology News:More than fish bait: Worms unlock secrets to new epilepsy treatments 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 2ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 3ORAL COTI-2 IS EFFECTIVE IN AN ANIMAL MODEL OF HUMAN PANCREATIC CANCER 4Germany starts its part in the International Cancer Genome Project 2Germany starts its part in the International Cancer Genome Project 3Germany starts its part in the International Cancer Genome Project 4
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
alpha/beta-Tubulin Antibody Ship: Hot Store: -20 C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Mouse monoclonal [CIG 3A11/5] to Cig2 (rating: *****) ( Abpromise for all tested applications)....
Biology Products: